Revolution Growth’s Latest Investment in Healthcare and AI: Pathos, the Company Re-Engineering the…
Revolution
OCTOBER 31, 2024
Revolution Growth’s Latest Investment in Healthcare and AI: Pathos, the Company Re-Engineering the Drug Development Process The oversubscribed $62M Series C will be used to expand the team, accelerate platform development, and advance its clinical-stage pipeline of precision oncology therapeutics.
Let's personalize your content